# Trius Therapeutics Inc

Trius Therapeutics Inc is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** Trius Therapeutics Inc
- **Former names in filing history:** RX3 PHARMACEUTICALS INC (2006-03-07 to 2006-10-25)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001356857

## About

Trius Therapeutics Inc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001356857, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2013-03-13, it reported annual revenue of USD 27,185,000; net income of USD -53,928,000; total assets of USD 75,274,000 for the fiscal period ended 2012-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2012 (period ended 2012-12-31)

- **Revenue:** $27.2M (USD 27,185,000)
- **Net income:** -$53.9M (USD -53,928,000)
- **Total assets:** $75.3M (USD 75,274,000)
- **Cash and equivalents:** $16.4M (USD 16,370,000)
- **Operating cash flow:** -$49.5M (USD -49,497,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $41.0M (USD 41,011,000)
- **Net income:** -$18.3M (USD -18,250,000)
- **Total assets:** $68.1M (USD 68,125,000)
- **Cash and equivalents:** $11.4M (USD 11,381,000)
- **Operating cash flow:** -$13.2M (USD -13,242,000)

## Recent SEC filings

- Form 8-K — filed 2013-09-11 — period 2013-09-11 — 8-K
- Form SC 13D — filed 2013-08-09 — SC 13D
- Form 10-Q — filed 2013-08-07 — period 2013-06-30 — FORM 10-Q
- Form 8-K — filed 2013-08-06 — period 2013-08-06 — FORM 8-K
- Form 8-K — filed 2013-08-01 — period 2013-07-30 — FORM 8-K
- Form 8-K — filed 2013-07-25 — period 2013-07-22 — FORM 8-K
- Form 8-K — filed 2013-05-24 — period 2013-05-21 — FORM 8-K
- Form 10-Q — filed 2013-05-08 — period 2013-03-31 — FORM 10-Q
- Form 8-K — filed 2013-05-07 — period 2013-05-07 — FORM 8-K
- Form DEF 14A — filed 2013-04-15 — period 2013-05-21 — DEF 14A
- Form 8-K — filed 2013-04-03 — period 2013-04-01 — FORM 8-K
- Form 8-K — filed 2013-03-25 — period 2013-03-25 — FORM 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/trius-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology